BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37015898)

  • 1. Construction of the prognostic model for small-cell lung cancer based on inflammatory markers: A real-world study of 612 cases with eastern cooperative oncology group performance score 0-1.
    Liu C; Jin B; Liu Y; Juhua O; Bao B; Yang B; Liu X; Yu P; Luo Y; Wang S; Teng Z; Song N; Qu J; Zhao J; Chen Y; Qu X; Zhang L
    Cancer Med; 2023 Apr; 12(8):9527-9540. PubMed ID: 37015898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    Dang J; Xu G; Guo G; Zhang H; Shang L
    J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
    Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
    Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
    Liang M; Chen M; Singh S; Singh S
    Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.
    Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P
    J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms based on the lymphocyte-albumin-neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive radiotherapy.
    Zhang S; Chen Z; Ling J; Feng Y; Xie Y; Liu X; Hu C; Hou T
    Sci Rep; 2024 Mar; 14(1):5388. PubMed ID: 38443675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China.
    Song Z; Ma H; Sun H; Li Q; Liu Y; Xie J; Feng Y; Shang Y; Ma K; Zhang N; Wang J
    BMC Cancer; 2023 Dec; 23(1):1182. PubMed ID: 38041067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
    Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
    Front Public Health; 2022; 10():946299. PubMed ID: 36159305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis.
    Ge T; Zhu S; Sun L; Yin L; Dai J; Qian J; Chen X; Zhang P; Zhu J; Jiang G
    Front Oncol; 2022; 12():921365. PubMed ID: 36465408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
    Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
    Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of nomogram based on pre-treatment inflammatory markers in patients with pulmonary-only synchronous metastases from colorectal cancer.
    Chen L; Li Q; Wang Y; Yang J; Ma X
    Int Immunopharmacol; 2019 Dec; 77():106001. PubMed ID: 31734191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pleural invasion on survival of patients with small cell lung cancer: Propensity score analysis and nomogram establishment based on the SEER database.
    Yang J; Yin H; Liu M; Zou G; Yu B
    Front Surg; 2023; 10():1108732. PubMed ID: 36911624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
    Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
    BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients.
    Zeng Q; Li J; Tan F; Sun N; Mao Y; Gao Y; Xue Q; Gao S; Zhao J; He J
    Ann Surg Oncol; 2021 Sep; 28(9):4893-4904. PubMed ID: 33655361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach.
    Zhao J; He Y; Yang X; Tian P; Zeng L; Huang K; Zhao J; Zhou J; Zhu Y; Wang Q; Chen M; Li W; Gao Y; Zhang Y; Xia Y
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic risk stratification model for metastatic small-cell lung cancer: An analysis of the SEER database.
    Qie S; Shi H; Wang F; Liu F; Zhang X; Li Y; Sun X
    Medicine (Baltimore); 2022 Oct; 101(42):e31000. PubMed ID: 36281112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy.
    Wu Y; Lv C; Lin M; Hong Y; Du B; Yao N; Zhu Y; Ji X; Li J; Lai J
    Front Immunol; 2023; 14():1297188. PubMed ID: 38022521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.